
CP-LC-1074 is a homocysteine-derived ионизируемый cationic липид that enables highly efficient in vivo delivery of various RNA therapeutics (including mRNA, cRNA, and saRNA) with robust protein expression. When formulated in standard LNP compositions (50:38.5:10:1.5 molar ratio of ионизируемый липид:cholesterol:DOPE:PEG-липид), it demonstrates superior lung-specific targeting compared to commercial alternatives following intravenous administration, while maintaining an excellent safety profile.
CP-LC-1074 is a homocysteine-derived ionizable cationic lipid that enables highly efficient in vivo delivery of various RNA therapeutics (including mRNA, cRNA, and saRNA) with robust protein expression. When formulated in standard LNP compositions (50:38.5:10:1.5 molar ratio of ionizable lipid:cholesterol:DOPE:PEG-lipid), it demonstrates superior lung-specific targeting compared to commercial alternatives following intravenous administration, while maintaining an excellent safety profile.
Вращайте мышью · Колесо — масштаб
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.